Cardiovascular risk factors in males with hypertriglycemic waist (Tehran Lipid and Glucose Study)

BACKGROUND: Many studies performed on nontraditional risk factors have proposed a metabolic triad including increased serum level of apolipoprotein B, hyperinsulinemia and high small, dense LDL-C as a risk factor of cardiovascular diseases. Hypertriglycemic waist (increased waist circumference as well as high fasting triglyceride level) can be used as a simple criterion to predict the metabolic triad. The aim of this study was to investigate the prevalence of hypertriglycemic waist and the frequency of cardiovascular risk factors in the affected population.MATERIALS AND METHODS: The study was performed on 4169, 18–70 y-old male subjects of the population of Tehran Lipid and Glucose Study (TLGS). The subjects fell into four groups with respect to serum level of fasting triglycerides (Tg) and waist circumference (WC). Subjects of group 1 had serum Tg ≥1.8 mmol/l as well as WC ≥95 cm, while those of group 2 had Tg ≥1.8 mmol/l and WC <95 cm. The triglycerides level was less than 1.8 mmol/l in groups 3 and 4, whereas WC was ≥95 cm and lower than 95 cm, respectively. Cardiovascular risk factors, anthropometric and laboratory variables were compared between the groups.RESULTS: In total, 784 subjects had high serum levels of Tg as well as increased WC. The mean age of subjects was significantly higher in groups 1 and 3 compared to others (37±15, 48±14, 41+13 and 46±13 y of age in groups 4, 3, 2 and 1, respectively, P<0.001). The prevalence of cardiovascular risk factors was significantly higher in group 1 as compared with others. Systolic and diastolic blood pressure, body mass index and WC were significantly higher in group 1 than in the others. Serum total cholesterol, Tg and LDL-C were significantly higher in group 1 compared to others, whereas HDL-C was significantly lower in this group. The prevalence of subjects who had at least four risk factors was 75 and 8% in groups 1 and 4, respectively.CONCLUSION: Hypertriglycemic waist can be used as a simple criterion to predict cardiovascular risk factors.

[1]  C. Bouchard,et al.  The small, dense LDL phenotype as a correlate of postprandial lipemia in men. , 2000, Atherosclerosis.

[2]  J. Després,et al.  Prevalence of 'hypertriglyceridemic waist' in men who participated in the Quebec Health Survey: association with atherogenic and diabetogenic metabolic risk factors. , 2002, Canadian Journal of Cardiology.

[3]  A. Onat,et al.  Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels--a prospective and cross-sectional evaluation. , 2002, Atherosclerosis.

[4]  M. Safar,et al.  Accumulation of Triglyceride-Rich Lipoprotein in Subjects With Abdominal Obesity: The Biguanides and the Prevention of the Risk of Obesity (BIGPRO) 1 Study , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[5]  F X Pi Sanyer.  THE OBESITY EPIDEMIC: PATHOPHYSIOLOGY AND CONSEQUENCES OF OBESITY , 2002 .

[6]  J. Després,et al.  Contribution of abdominal obesity and hypertriglyceridemia to impaired fasting glucose and coronary artery disease. , 2002, The American journal of cardiology.

[7]  T. Katagiri,et al.  Significance of small dense low-density lipoproteins and other risk factors in patients with various types of coronary heart disease. , 2002, American heart journal.

[8]  E. Hawe,et al.  Nonfasting Apolipoprotein B and Triglyceride Levels as a Useful Predictor of Coronary Heart Disease Risk in Middle-Aged UK Men , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[9]  Nicaud,et al.  Postprandial response to a fat tolerance test in young adults with a paternal history of premature coronary heart disease — the EARS II study , 2000, European journal of clinical investigation.

[10]  S. Allahverdian,et al.  Serum lipid levels in an Iranian population of children and adolescents: Tehran lipid and glucose study , 2004, European Journal of Epidemiology.

[11]  G. Dagenais,et al.  High apolipoprotein B with low high-density lipoprotein cholesterol and normal plasma triglycerides and cholesterol. , 2001, The American journal of cardiology.

[12]  D. Gaudet,et al.  Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? , 2000, Circulation.

[13]  G. Dagenais,et al.  Hyperinsulinemia as an independent risk factor for ischemic heart disease. , 1996, The New England journal of medicine.

[14]  A. Golay,et al.  Relationship between hyperinsulinemia and angiographically defined coronary atherosclerosis in non-diabetic men. , 2002, Diabetes & metabolism.

[15]  A. Sharrett,et al.  Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease. The Atherosclerosis Risk in Communities (ARIC) Study. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[16]  A. Voors,et al.  Usefulness of hypertriglyceridemia in predicting myocardial infarction late after coronary artery bypass operation. , 1997, The American journal of cardiology.

[17]  M. Haidari,et al.  Apolipoprotein B as the best predictor of coronary artery disease in Iranian normolipidemic patients. , 2001, Clinical biochemistry.

[18]  M. Sorrentino,et al.  CME Credit Article: Does Hypertriglyceridemia Increase Risk for CAD?: Growing Evidence Suggests it Plays a Role , 2000, Postgraduate medicine.

[19]  J. Yarnell,et al.  Insulin in ischaemic heart disease: are associations explained by triglyceride concentrations? The Caerphilly prospective study. , 1994, British heart journal.

[20]  I. Holme,et al.  Apolipoprotein B and A-I values in 147576 Swedish males and females, standardized according to the World Health Organization-International Federation of Clinical Chemistry First International Reference Materials. , 1998, Clinical chemistry.

[21]  F. Azizi,et al.  Association of lipids, lipoproteins, apolipoproteins and paraoxonase enzyme activity with premature coronary artery disease , 2002, Coronary artery disease.

[22]  J. Després,et al.  Health consequences of visceral obesity , 2001, Annals of medicine.